3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical co

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544105, C07D27301, C07D41302

Patent

active

054201268

ABSTRACT:
Novel benzoxazine derivatives of the formula (I): ##STR1## are provided as well as their pharmaceutically acceptable salts and a method for their use as potassium channel activating agents 2-(3,4-Dihydro-2, 2-dimethyl-6-phenylsulfonyl-2H-1,4-benzoxazin-4-yl)pyridine N-oxide is illustrative of a benzoxazine derivative of formula (I). Also provided are intermediate compounds such as those of formula (II): ##STR2##

REFERENCES:
patent: 3879522 (1975-04-01), Pesson
patent: 4721784 (1988-01-01), Combs
patent: 4798620 (1989-01-01), Kume et al.
patent: 4826985 (1989-05-01), Mitscher et al.
patent: 4962200 (1990-10-01), Kihara et al.
patent: 5055110 (1991-10-01), Lim et al.
E. I. Du Pont de Nemours & Co, Chem. Abstract vol. 85:144672y, (1976).
Ge et al, Chem. Abstract vol. 110:192749k (1988), and Stn Printout.
Bigg et al., Chem. Abstract vol. 105: 133897f (1986).
Teulon, Chem. Abstract vol. 104: 109668r (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical co will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-361958

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.